Six-year epidemiological dynamics of human respiratory syncytial virus infections in children in central China (2019-2024): pandemic suppression, 2023 resurgence, and immune debt effect
Frontiers in Cellular and Infection Microbiology · 2026
DOI: 10.3389/fcimb.2025.1691957 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2026. Verfasst von Zhiyi Xia und 5 weiteren Autor:innen. Beteiligte Einrichtung: Henan Children's Hospital Zhengzhou Children's Hospital, Zhengzhou, China. Hauptthemen laut MEDLINE: Respiratory Syncytial Virus Infections, Respiratory Syncytial Virus, Human, COVID-19. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Human respiratory syncytial virus (HRSV) is a leading cause of acute respiratory infections in children. COVID-19 NPIs significantly suppressed HRSV transmission. This study analyzed six-year epidemiological dynamics of pediatric HRSV infections in Henan Province, China, focusing on NPI suppression effects, the 2023 resurgence, and “Immune debt” impact.
Methods
We retrospectively collected respiratory specimens from 80,920 children with acute respiratory diseases at Henan Children’s Hospital (2019-2024). HRSV was detected using RT-qPCR. Positivity rates were analyzed by year, season, and age group.
Results
During 2019–2024, HRSV positivity fluctuated markedly: 14.65% (2019), 16.34% (2021), 3.27% (2022 under strict NPIs), 21.47% (2023 post-NPIs), and 6.80% (2024). Interrupted time-series analysis indicated that NPI lifting in 2023 was associated with a significant surge in infection risk (OR = 668.77, 95% CI: 47.03–9509.28). Seasonal patterns shifted substantially, with the characteristic winter peak replaced by an off-season spring outbreak in April 2023 (57.41%). Multivariable logistic regression identified age as the strongest predictor, with infants <1 year having the highest risk (aOR = 9.02, 95% CI: 8.31–9.79) and a 4.91-fold higher positivity rate than school-aged children (22.98% vs. 4.68%; 95% CI: 4.59–5.25; P < 0.001).
Conclusions
NPIs dramatically affected HRSV epidemiology. The intense post-suppression rebound strongly supports the “Immune debt” theory—accumulation of susceptible children driving resurgence. Establishing year-round, multi-pathogen surveillance systems is crucial for post-pandemic public health challenges.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Henan Children's Hospital Zhengzhou Children's Hospital, Zhengzhou, China.
- Henan International Joint Laboratory of Children's Infectious Diseases, Children's Hospital Affiliated to Zhengzhou University, Henan Children's Hospital Zhengzhou Children's Hospital, Zhengzhou, China.
- Laboratory of Molecular Epidemiology and Evolutionary Genetics, Saint Petersburg Pasteur Institute, Saint-Petersburg, Russia.
- Children's Medical Research Institute of Henan Academy of Medical Sciences, Zhengzhou, China.
Zitieren
APA
Xia, Z., Li, X., Shen, A., Mokrousov, I., Guo, P., & Zhang, Y. (2026). Six-year epidemiological dynamics of human respiratory syncytial virus infections in children in central China (2019-2024): pandemic suppression, 2023 resurgence, and immune debt effect. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2025.1691957
Vancouver
Xia Z, Li X, Shen A, Mokrousov I, Guo P, Zhang Y. Six-year epidemiological dynamics of human respiratory syncytial virus infections in children in central China (2019-2024): pandemic suppression, 2023 resurgence, and immune debt effect. Frontiers in Cellular and Infection Microbiology. 2026. doi:10.3389/fcimb.2025.1691957
BibTeX
@article{Xia2026,
author = {Xia, Zhiyi and Li, Xue and Shen, Adong and Mokrousov, Igor and Guo, Pengbo and Zhang, Yaodong},
title = {Six-year epidemiological dynamics of human respiratory syncytial virus infections in children in central China (2019-2024): pandemic suppression, 2023 resurgence, and immune debt effect},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2026},
doi = {10.3389/fcimb.2025.1691957}
}
EUVIMED